• MS pipeline for biologically active substances developed
    A coherent pipeline for MS analysis of biologically active substances has been devised


MS pipeline for biologically active substances developed

Aug 27 2010

A mass spectrometry (MS) pipeline designed to facilitate the analysis of biologically active substances has been developed by scientists.

The team from the UK Health Protection Agency worked to create the first coherent pipeline for the process, with their findings published in the latest issue of BMC Bioinformatics.

While MS has been indicated as a suitable way to discover novel biomarkers in the past, the scientists argue that no cohesive procedure has been in place for doing so.

Now they have devised a four-stage approach, beginning with a sample preparation phase.

The MS analysis itself forms the second part of the process, while in the third phase databases are searched using the outcomes of the spectrometry.

Finally, the appropriate biomarkers are validated, a stage the researchers say is "vital for discovery of robust biomarkers".

BMC Bioinformatics is peer-reviewed and published online with open access, covering topics such as statistical and computational methods for analysing biologically active substances.

Digital Edition

Chromatography Today - Buyers' Guide 2022

December 2021

In This Edition Modern & Practocal Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions


Lab Asia 2023

Oct 10 2023 Hybrid event

MicroTAS 2023

Oct 15 2023 Katowice, Poland

ISPPP 2023

Nov 05 2023 Vienna, Austria

SETAC North America

Nov 12 2023 Louisville, KY, USA

Eastern Analytical Symposium

Nov 13 2023 Plainsboro, NJ, USA

View all events